S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China

GeoVax Labs Stock Price, News & Analysis (NASDAQ:GOVXW)

$0.10
+0.02 (+25.35%)
(As of 12/1/2023 ET)
Compare
Today's Range
$0.09
▼
$0.10
50-Day Range
$0.04
▼
$0.15
52-Week Range
$0.04
▼
$0.35
Volume
300 shs
Average Volume
3,870 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media

GOVXW stock logo

About GeoVax Labs Stock (NASDAQ:GOVXW)

geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic vaccines for chronic hepatitis b infections and cancers. our mva-vlp platform supports in vivo production of non-infectious vlps from the cells of the very person receiving the vaccine, mimicking a natural infection, and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. for more information, visit www.geovax.com.

GOVXW Stock Price History

GOVXW Stock News Headlines

November 14, 2023 | finance.yahoo.com
Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
November 8, 2023 | finance.yahoo.com
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
December 2, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
October 30, 2023 | finance.yahoo.com
GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
October 25, 2023 | finance.yahoo.com
GeoVax to Participate in Upcoming November Investor and Industry Events
October 9, 2023 | finance.yahoo.com
GeoVax Receives Notice of Allowance for Marburg Vaccine Patent
October 5, 2023 | finance.yahoo.com
GeoVax Receives Notice of Allowance for HIV Vaccine Patent
September 26, 2023 | finance.yahoo.com
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
December 2, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
September 20, 2023 | finance.yahoo.com
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
August 29, 2023 | finance.yahoo.com
GeoVax to Present at the Emerging Growth Conference on September 6, 2023
August 10, 2023 | finance.yahoo.com
GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
August 9, 2023 | finance.yahoo.com
GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update
July 24, 2023 | marketwatch.com
GeoVax Labs Shares Rise 8% After Patent for Ebola Vaccine
July 11, 2023 | finance.yahoo.com
GOVX - GeoVax Labs, Inc.
July 10, 2023 | finance.yahoo.com
GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference
May 24, 2023 | finance.yahoo.com
GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
May 9, 2023 | finance.yahoo.com
GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference
May 8, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Selecta Biosciences (SELB) and Assembly Biosciences (ASMB)
April 26, 2023 | finance.yahoo.com
GeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Host
April 25, 2023 | finance.yahoo.com
GeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023
April 6, 2023 | finanznachrichten.de
GeoVax, Inc.: GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate
March 27, 2023 | finance.yahoo.com
GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2022 Earnings Call Transcript
March 24, 2023 | finanznachrichten.de
GeoVax, Inc.: GeoVax Reports 2022 Year-End Financial Results and Provides Corporate Update
February 8, 2023 | finance.yahoo.com
GeoVax Announces Decisive Progress in Establishing High-Capacity, Continuous Cell Line System to Manufacture MVA-based Vaccines
November 9, 2022 | finance.yahoo.com
GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update
October 26, 2022 | finance.yahoo.com
GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022
See More Headlines
Receive GOVXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeoVax Labs and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Research & Development In Biotechnology
Sub-Industry
N/A
Sector
Business Services
Current Symbol
NASDAQ:GOVXW
CUSIP
N/A
CIK
832489
Web
www.geovax.com
Phone
16783847220
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$81,526.00
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report














GOVXW Stock Analysis - Frequently Asked Questions

How have GOVXW shares performed in 2023?

GeoVax Labs' stock was trading at $0.15 at the beginning of 2023. Since then, GOVXW shares have decreased by 34.1% and is now trading at $0.0989.
View the best growth stocks for 2023 here.

Are investors shorting GeoVax Labs?

GeoVax Labs saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,300 shares, an increase of 44.4% from the October 31st total of 900 shares. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 0.7 days.
View GeoVax Labs' Short Interest.

How do I buy shares of GeoVax Labs?

Shares of GOVXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GOVXW) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -